The historical rank and industry rank for Danimer Scientific's Net Cash per Share or its related term are showing as below:
During the past 5 years, the highest Price-to-Net-Cash Ratio of Danimer Scientific was 10.59. The lowest was 10.59. And the median was 10.59.
DNMR's Price-to-Net-Cash is not ranked *
in the Chemicals industry.
Industry Median: 8.83 * Ranked among companies with meaningful Price-to-Net-Cash only.
Danimer Scientific Net Cash per Share Historical Data
The historical data trend for Danimer Scientific's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Danimer Scientific's Net Cash per Share
For the Specialty Chemicals subindustry, Danimer Scientific's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Danimer Scientific's Price-to-Net-Cash Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Danimer Scientific's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Danimer Scientific's Price-to-Net-Cash falls into.
Danimer Scientific Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Danimer Scientific's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danimer Scientific (NYSE:DNMR) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Danimer Scientific Net Cash per Share Related Terms
Thank you for viewing the detailed overview of Danimer Scientific's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Danimer Scientific (Danimer Scientific) Business Description
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DNMR has been successfully added to your 